Related Experiment Video
Updated: May 12, 2026
Nuclei Isolation from Mouse Cardiac Progenitor Cells for Epigenome and Gene Expression Profiling at Single-Cell Resolution
Published on: May 12, 2023
Gene expression analysis in cardiac tissues from infants identifies candidate agents for Tetralogy of Fallot
Dicheng Yang1, Jing Li, Zhongxiang Yuan
1Department of Cardiovascular Surgery, Shanghai First People's Hospital, Shanghai Jiao Tong University, Shanghai, 200080, China.
Abstract:
Tetralogy of Fallot (TOF) is the most common cyanotic heart defect and the most common cause of blue baby syndrome. Although great progress has been made, the molecular mechanisms of TOF are far from being fully understood, and treatment of this disease remains palliative. In this study, we downloaded gene expression data of TOF subjects with those of normally developing subjects from the Gene Expression Omnibus database and employed computational bioinformatics analyses to compare their gene expression patterns. Furthermore, small molecules that induce inverse gene changes to TOF were identified. A total of 2,274 genes involved in energy metabolism and protein binding were differentially expressed in TOF samples compared with samples from normal controls. Pathways associated with cellular oxygen tension were dysfunctional. In addition, we identified a group of small molecules that may be exploited as adjuvant drug to alleviate some symptoms for TOF patients. These drugs are clearly a direction that warrants additional consideration.
Insights
Tetralogy of Fallot (TOF), a common blue baby syndrome cause, involves altered energy metabolism and protein binding genes. Researchers identified potential small molecule drugs to help manage TOF symptoms.
Area of Science:
- Cardiovascular Science
- Genomics
- Bioinformatics
Background:
- Tetralogy of Fallot (TOF) is the most frequent cyanotic heart defect, leading to blue baby syndrome.
- Current understanding of TOF molecular mechanisms is incomplete, and treatments are primarily palliative.
Purpose of the Study:
- To compare gene expression patterns between TOF patients and healthy individuals.
- To identify molecular targets and potential therapeutic small molecules for TOF.
Main Methods:
- Downloaded and analyzed gene expression data from the Gene Expression Omnibus database.
- Utilized computational bioinformatics to compare TOF and control samples.
- Identified small molecules that could reverse TOF-associated gene expression changes.
Main Results:
- 2,274 genes related to energy metabolism and protein binding were differentially expressed in TOF.
- Pathways regulating cellular oxygen tension were found to be dysfunctional in TOF.
- A selection of small molecules with potential therapeutic applications was identified.
Conclusions:
- Significant molecular differences exist in TOF, particularly in energy metabolism and oxygen tension pathways.
- Identified small molecules represent a promising avenue for adjuvant therapy in TOF patients.
- Further research into these small molecules could lead to improved TOF symptom management.
